Early IVIG Reduces Infections in Transplant Patients
A clinical trial at the Universidad Autónoma de Madrid (UAM) suggests that early administration of intravenous immune globulin (IVIG) could decrease the occurrence of new infections in transplanted individuals who present with hypogammaglobulinemia.
FDA Approves atezolizumab to Treat dMMR Colon Cancer
The Food and Drug Administration has approved atezolizumab in combination with fluoropyrimidine and oxaliplatin for the adjuvant treatment of adult and pediatric patients 2 years of age and older with stage III mismatch repair deficient colon cancer
FDA Approves IMAAVY to Treat Warm Autoimmune Hemolytic Anemia
The U.S. Food and Drug Administration (FDA) has approved IMAAVY (nipocalimab-aahu) to treat warm autoimmune hemolytic anemia (wAIHA), a rare, life-threatening autoantibody disease, in adults and pediatric patients 12 years of age and older currently or previously treated with corticosteroids. The approval, which follows FDA priority review, marks the first time a therapy was proven […]
FDA Approves Elecsys pTau217 to Identify Alzheimer’s in Individuals 55 Years and Older
The U.S. Food and Drug Administration (FDA) has cleared the Elecsys Phospho-Tau (217P) Plasma (pTau217) blood test, providing clinicians across primary and specialty care with a single blood-based option to aid in identifying amyloid pathology associated with Alzheimer’s disease in individuals 55 years and older with signs, symptoms or complaints of cognitive decline. Developed in […]
Gamgertamig Is Approved by FDA to Treat Pemphigus
Lakefront’s Gamgertamig has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) to treat pemphigus. The drug is being developed by Lakefront in collaboration with Gilead Sciences. Ongoing clinical trials in autoimmune diseases are actively enrolling, and expansion of the clinical trials program is anticipated in 2027. These include: A Phase […]
FDA Approves KERENDIA to Treat Chronic Kidney Disease Associated with Type 1 Diabetes in Adults
The U.S. Food and Drug Administration has approved KERENDIA (finerenone) for adults with chronic kidney disease associated with type 1 diabetes.
CDC Merges Flu and COVID Divisions
The Centers for Disease Control and Prevention is merging its Influenza Division with the Coronavirus and Other Respiratory Diseases Division to create the Influenza and Respiratory Viruses Division.
CDC Issues Recommendations for 2026-2027 Influenza Vaccines
The Centers for Disease Control and Prevention has issues its recommendations for use of the seasonal 2026-2027 influenza (flu) vaccines.
FDA Approves Lisraya to Treat Dermatomyositis
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets to treat dermatomyositis in adults.
New COVID Vaccines Approved by FDA
Updated COVID-19 vaccines from Moderna, Novavax-Sanofi and Pfizer-BioNTech have been approved by the U.S. Food and Drug Administration.